First Aid and Prognosis for Acute Pneumonia
Article Sidebar
Main Article Content
Abstract
Acute inflammation of the lung tissue, despite the constantly declared reports on the achievement of success in the treatment of these processes, remains one of the urgent problems of modern medicine, having turned in recent years into a subject of concern and unpredictability of the final results. The reason for this state in solving this problem is the inattention to a number of side effects of antibiotics, which still play the role of the main therapeutic agent for these diseases. The hope for a narrowly targeted antimicrobial action of these drugs leaves aside the classical canons of medical science. All the noted facts indicate the decisive role of didactic education under the influence of antibiotics in choosing adequate and effective solutions.
Downloads
Article Details
Copyright (c) 2024 Klepikov I.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Avery OT, Chickering HT, Cole RI, Dochez AR. Acute lobar pneumonia: prevention and serum treatment. Monographs of the Rockefeller Institute for Medical Research. Rockefeller Institute for Medical Research, New York. 1917. Available from: https://search.worldcat.org/title/acute-lobar-pneumonia-prevention-and-serum-treatment/oclc/2387617
Cole RI. Acute pulmonary infections. De La Mar Lectures. Williams & Wilkins, Baltimore. 1927–1928
Sutliff WD, Finland M. The significance of the newly classified types of pneumococci in disease: types IV to XX inclusive. JAMA. 1933;101(17):1289-1295. Available from: https://jamanetwork.com/journals/jama/article-abstract/245616
Heffron R. Pneumonia, with special reference to pneumococcus lobar pneumonia. Cambridge: Harvard University Press; 1939. Available from: https://wellcomecollection.org/works/eyms2svh
Small JT. A short history of the pneumococcus with special reference to lobar pneumonia. Edinb Med J. 1948;55(3):129–41. Available from: https://pubmed.ncbi.nlm.nih.gov/18914591/
Domagk G. A contribution to the chemotherapy of bacterial infections". German Medical Weekly. 1935; 61 (7): 250-253. Available from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0028-1129486
Tréfouël J, Tréfouël T, Nitti F, Bovet D. Activity of p-minophenylsulfonamide on experimental streptococcal infection of mice and rabbits. C. R. Soc. Biol. 1935; 120: 756.
Fleming A. Streptococcal Meningitis treated With Penicillin. The Lancet. 1943; 242 (6267): 434–438. Available from: https://doi.org/10.1016/S0140-6736(00)87452-8
Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. 1940. Rev Infect Dis. 1940;1988;10(4):677–678. Available from: https://pubmed.ncbi.nlm.nih.gov/3055168/
Rammelkamp T. Resistance of Staphylococcus aureus to the action of penicillin. Exp Biol Med. 1942;51:386–389. Available from: https://doi.org/10.3181/00379727-51-13986
Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Frontiers in Microbiology. 2010; 1: 134. Available from: https://doi.org/10.3389/fmicb.2010.00134
Metlay JP, Waterer GW, Long AC, Long AC, Anzueto A, Brozek J, et al. On behalf of the American Thoracic Society and Infectious Diseases Society of America. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 2019; 200(7):e45-e67. Available from: https://doi.org/10.1164/rccm.201908-1581ST
Peyrani P, Mandell L, Torres A, Tillotson GS. The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance. Expert Review of Respiratory Medicine.2019; 13:2, 139-152. Available from: https://doi.org/10.1080/17476348.2019.1562339
Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023;49(6):615-632. Erratum in: Intensive Care Med. 2023;49(8):1040-1041. Available from: https://doi.org/10.1007/s00134-023-07033-8
Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008; 86:408–416. Available from: https://doi.org/10.2471/blt.07.048769
Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011;377 (9773): 1264–75. Available from: https://www.thelancet.com/article/S0140-6736(10)61459-6/fulltext
Antiviral drug. Wikipedia. Available from: https://en.wikipedia.org/wiki/Antiviral_drug
Ferrer M, Travierso C, Cilloniz C, Gabarrus A, Ranzani OT, Polverino E, et al. Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS One. 2018;13(1):e0191721. Available from: https://doi.org/10.1371/journal.pone.0191721
Cavallazzi R, Furmanek S, Arnold FW, Beavin LA, Wunderink RG, Niederman MS, et al. The burden of community-acquired pneumonia requiring admission to ICU in the United States. Chest. 2020; 158:1008–1016. Available from: https://doi.org/10.1016/j.chest.2020.03.051
Chalmers S, Khawaja A, Wieruszewski PM, Gajic O, Odeyemi Y. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers. World J Crit Care Med. 2019; 8(5):59-71. Available from: https://doi.org/10.5492/wjccm.v8.i5.59
Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet. 2015; 386 (9998): 1097–108. Available from: https://doi.org/10.1016/s0140-6736(15)60733-4
Rollas K, Ersan G, Zincircioğlu, Sahar I, Çalişkan T, Güldogan IK, et al. Septic shock in patients admitted to intensive care unit with COVID-19 pneumonia. Eurasian J Pulmonol. 2021;23:95-100. Available from: https://eurasianjpulmonol.com/storage/upload/pdfs/1639396765-en.pdf
Heneghan C, Plueddemann A, Mahtani KR. Differentiating viral from bacterial pneumonia. The Centre for Evidence-Based Medicine. Evidence Service to support the COVID-19 response. University of Oxford. 2020. Available from: https://www.cebm.net/covid-19/differentiating-viral-from-bacterial-pneumonia/
Kamat IS, Ramachandran V, Eswaran H, Guffey D, Master DM. Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis. Clin Infect Dis. 2020;70(3):538-542. Available from: https://doi.org/10.1093/cid/ciz545
Lhommet C, Garot D, Grammatico-Guillon L, Jourdannaud C, Asfar P, Faisy C, et al. Predicting the microbial cause of community-acquired pneumonia: can physicians or a data-driven method differentiate viral from bacterial pneumonia at patient presentation? BMC Pulm Med. 2020;20(1):62. Available from: https://doi.org/10.1186/s12890-020-1089-y
Oran DP, Topol EJ. Prevalence of asymptomatic SARS‐CoV‐2 infection. Ann Intern Med. 2020; 173:362–367. Available from: https://doi.org/10.7326/m20-3012
Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355-362. Epub 2020 May 6. Erratum in: Nat Rev Immunol. 2020;20(7):448. Available from: https://doi.org/10.1038/s41577-020-0331-4
Zhou, B, Kojima, S, Kawamoto, A, Fukushima, M. COVID‐19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. J Med Virol. 2021; 1–11. Available from: https://doi.org/10.1002/jmv.26754
Alene M, Yismaw L, Assemie MA, Ketema DB, Mengist B, Cassie B, Birhan TY. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis. PLoS One. 2021 Mar 23;16(3): e0249090. Available from: https://doi.org/10.1371/journal.pone.0249090
Sinha P. Severe Viral Lower Respiratory Tract Infections Pose a Significant Burden on Patients and Healthcare Systems. Respir AMJ. 2023;1[1]:26-35.
Meyer N. Dysregulated Host Immune Response is the Driver of Disease Progression and Severe Patient Outcomes. Respir AMJ. 2023;1[1]:26-35. Available from: https://doi.org/10.33590/respiramj/10304417
Klepikov I. The Didactics of Acute Lung Inflammation. Cambridge Scholars Publishing, 2022; 320. Available from: https://www.cambridgescholars.com/product/978-1-5275-8810-3
Klepikov I. Myths, Legends and Real Facts About Acute Lung Inflammation. Cambridge Scholars Publishing. 2024;338. Available from: https://www.cambridgescholars.com/product/978-1-0364-0293-8
Schwiegk H. Der Lungenentlastungsreflex. Pflügers Arch. ges. Physiol. 1935; 236:206–219. Available from: https://link.springer.com/article/10.1007/BF01752336
Thillai M, Patvardhan C, Swietlik EM, McLellan T, De Backer J, Lanclus M, et al. Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19. Thorax. 2021;76(2):182-184. Available from: https://doi.org/10.1136/thoraxjnl-2020-215395
Dierckx W, De Backer W, Links M, De Meyer Y, Ides K, et al. CT-derived measurements of pulmonary blood volume in small vessels and the need for supplemental oxygen in COVID-19 patients. Journal of Applied Physiology 2022; 133:6:1295-1299. Available from: https://doi.org/10.1152/japplphysiol.00458.2022
Leiter RE. Reentry. NEJM, 2020. Available from: https://doi.org/10.1056/nejmp2027447
Rosenquist JN. The Stress of Bayesian Medicine - Uncomfortable Uncertainty in the Face of Covid-19. N Engl J Med. 2021;384(1):7-9. Available from: https://doi.org/10.1056/nejmp2018857
Salisbury H. Helen Salisbury: What might we learn from the covid-19 pandemic? BMJ. 2020;368:m1087. Available from: https://doi.org/10.1136/bmj.m1087
Oliver D. David Oliver: Conveyor belt medicine. BMJ. 2020;368:m162. Available from: https://doi.org/10.1136/bmj.m162
Morris AC. Management of pneumonia in intensive care. J Emerg Crit Care Med. 2018;2:101. Available from: https://jeccm.amegroups.org/article/view/4830/html
Cilloniz C, Torres A, Niederman MS. Management of pneumonia in critically ill patients BMJ. 2021; 375:e065871. Available from: https://www.scribd.com/document/545580640/bmj-2021-065871-full
Menéndez R, Méndez R, González-Jiménez P, Latorre A, Reyes S, Zalacain R, et al. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia. Sci Rep. 2024;14(1):12726. Available from: https://doi.org/10.1038/s41598-024-62718-4
Kolditz M, Ewig S, Klapdor B, Schütte H, Schütte J, Rupp J, et al. Community-acquired pneumonia as medical emergency: predictors of early deterioration. Thorax. 2015; 70:551–558. Available from: https://doi.org/10.1136/thoraxjnl-2014-206744